PDSBPDS Biotechnology Corporation

PDSB Stock Price, Valuation & Chart | PDS Biotechnology Corporation

Compare

$0.220+0.01 (+6.18%)

At close · 02 Sept 2026, 07:59 pm

Sector: Healthcare Industry: Biotechnology PDSB intrinsic value PDSB calculated fair value vs price

Overview Financials Dividends Ratios

PDSB Historical price chart

PDSB Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization12.11M

PE Ratio-0.32

EPS-0.67

Trading Volume757.11K

Today's High/Low0.22/0.2

Dividend Yield0.00

52 Week High/Low1.55/0.2

Shares Outstanding55.92M

PDSB Financial Statement

PDSB Analyst ratings

PDSB Analysis & performance metrics

PDSB Company profile

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101…

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also…

PDSB Management team

Name

Position

Janetta Trochimiuk

Controller

Lars Robert Boesgaard M.B.A.CFO

Principal Financial & Accounting Officer and Chief Financial Officer

Stephan Toutain M.B.A., M.S.COO

Chief Operating Officer

Kirk V. Shepard M.D.

Chief Medical Officer

Spencer Brown J.D.

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Frank K. Bedu-Addo Ph.D.CEO

President, Chief Executive Officer & Director

Gregory L. Conn Ph.D.

Chief Scientific Officer

Name

Position

Janetta Trochimiuk

Controller

Lars Robert Boesgaard M.B.A.CFO

Principal Financial & Accounting Officer and Chief Financial Officer

Stephan Toutain M.B.A., M.S.COO

Chief Operating Officer

Kirk V. Shepard M.D.

Chief Medical Officer

Spencer Brown J.D.

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Frank K. Bedu-Addo Ph.D.CEO

President, Chief Executive Officer & Director

Gregory L. Conn Ph.D.

Chief Scientific Officer

Management Team

Janetta Trochimiuk

Controller

Lars Robert Boesgaard M.B.A.CFO

Principal Financial & Accounting Officer and Chief Financial Officer

Stephan Toutain M.B.A., M.S.COO

Chief Operating Officer

Kirk V. Shepard M.D.

Chief Medical Officer

Spencer Brown J.D.

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Frank K. Bedu-Addo Ph.D.CEO

President, Chief Executive Officer & Director

Gregory L. Conn Ph.D.

Chief Scientific Officer

Management

Janetta Trochimiuk

Controller

Lars Robert Boesgaard M.B.A.CFO

Principal Financial & Accounting Officer and Chief Financial Officer

Stephan Toutain M.B.A., M.S.COO

Chief Operating Officer

Kirk V. Shepard M.D.

Chief Medical Officer

Spencer Brown J.D.

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Frank K. Bedu-Addo Ph.D.CEO

President, Chief Executive Officer & Director

Gregory L. Conn Ph.D.

Chief Scientific Officer

Total 7 executives

PDSB Frequently asked questions

What is PDS Biotechnology Corporation (PDSB) Stock Price?

Current stock price of PDS Biotechnology Corporation (PDSB) stock is $0.220. The stock price is +6.18% higher in the session. The intraday range can be seen from this page. Volume of PDS Biotechnology Corporation (PDSB) stock is 757.11K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the PDS Biotechnology Corporation (PDSB) stock price going up or down today?

The stock price of PDS Biotechnology Corporation (PDSB) can change with earnings, company news, and overall market sentiment. PDS Biotechnology Corporation operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the PDS Biotechnology Corporation stock expensive at its current price?

Whether PDS Biotechnology Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PDSB on this page is -0.32. EPS on this page is -0.67. Compare those figures with peers and growth expectations before deciding if the current PDS Biotechnology Corporation price is justified.

How has the stock price of PDS Biotechnology Corporation (PDSB) performed historically?

Historical performance for PDS Biotechnology Corporation (PDSB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PDSB reacted to past earnings and market events.

Should I buy PDS Biotechnology Corporation (PDSB) stock, at this price?

Buying PDS Biotechnology Corporation (PDSB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.